Remove 2014 Remove Development Remove Gordon Remove Management
article thumbnail

We Need More Transparency on the Cost of Specialty Drugs

Harvard Business Review

In a July 2014 JAMA article , Troyen Brennan and William Shrank, respectively the chief medical and scientific officers at CVS Caremark, a major pharmacy benefit manager (PBM), estimated that with as many as 3 million eligible HCV patients in the U.S., In one analysis , Gordon D. And yet plenty of other systems rate quality.

Cost 8
article thumbnail

We Need More Transparency on the Cost of Specialty Drugs

Harvard Business Review

In a July 2014 JAMA article , Troyen Brennan and William Shrank, respectively the chief medical and scientific officers at CVS Caremark, a major pharmacy benefit manager (PBM), estimated that with as many as 3 million eligible HCV patients in the U.S., In one analysis , Gordon D. And yet plenty of other systems rate quality.

Cost 8
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Applying Deming Principles at Small and Medium-sized Enterprises

Deming Institute

For more than 10 years now I have been helping people to develop their own Small and Medium-sized Enterprises (SME). In 2014, I applied for and received a grant from The W. Many of the clients I worked with had had developed the idea for years, but they were reluctant to quit their Jobs, or were afraid of failing.

Deming 28
article thumbnail

The H-1B Visa Debate, Explained

Harvard Business Review

The order is the latest development in a long-running debate over how companies use the H-1B program and how it affects American workers. According to an analysis by Ronil Hira, a professor of public policy at Howard University, in 2014 nearly one-third of new H-1B visas went to 13 of these so-called “outsourcers.”